FDA points its finger at an early-stage contract research organization for falsifying documents and manipulating samples.
The Scientist
Most Recent
As seven of the world’s top selling drugs expire over the next year, prescription prices are set to drop while generics fill in.
The surprising results when drug development and altruism collide
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
